Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
06/2010
06/17/2010US20100151548 vector with codon-optimised genes for an arabinose metabolic pathway for arabinose conversion in yeast for ethanol production
06/17/2010US20100151541 Novel polypeptide having esterase activity and recombinant esterase and use thereof
06/17/2010US20100151529 Engineered phosphite dehydrogenase mutants
06/17/2010US20100151524 Compositions and Methods for Increasing Bone Mineralization
06/17/2010US20100151520 Translation Enhancer Elements Of Genes Encoding Human Tau Protein and Human Alpha-Synuclein Protein
06/17/2010US20100151519 Method for production of isoprenoids
06/17/2010US20100151516 Gene SMS 13
06/17/2010US20100151502 Functional expression of triacylgylcerol lipases
06/17/2010US20100151486 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof
06/17/2010US20100151477 Reducing non-target nucleic acid dependent amplifications: amplifying repetitive nucleic acid sequences
06/17/2010US20100151476 Phenylthiocarbamide (ptc) taste receptor
06/17/2010US20100151464 Compositions and methods for preparing oligonucleotide solutions
06/17/2010US20100151458 Oligoribonucleotides and ribonucleases for cleaving rna
06/17/2010US20100151453 Dot1 histone methyltransferases as a target for identifying therapeutic agents for leukemia
06/17/2010US20100151449 Method for poduction of l-amino acids by fermentation
06/17/2010US20100151448 Asymmetric PCR Amplification, its Special Primer and Application
06/17/2010US20100151111 Polypeptides of Strain Bacillus SP. P203
06/17/2010US20100151096 Inhibition of ice crystal growth
06/17/2010US20100151051 Anti-tumor drug, medicament, composition, and use thereof
06/17/2010US20100151007 Compositions and methods for selective inhibition of vegf
06/17/2010US20100151003 Egfr binding peptides and uses thereof
06/17/2010US20100150965 Dna promoters and anthrax vaccines
06/17/2010US20100150959 PCV 2-Based Methods and Compositions for the Treatment of Pigs
06/17/2010US20100150941 Hemagglutinin antibody and uses thereof
06/17/2010US20100150939 Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
06/17/2010US20100150937 Antagonists of pcsk9
06/17/2010US20100150929 Peptide Associated with Rheumatic Fever (PARF) and Its Use as a Diagnostic Marker
06/17/2010US20100150926 Fusion protein capable of binding vegf-a and tnf-alpha
06/17/2010US20100150924 Regulation of myelination by nectin-like (necl) molecules
06/17/2010US20100150923 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses
06/17/2010US20100150918 Cross-species-specific binding domain
06/17/2010US20100150916 huTNFR1 Selective Antagonists
06/17/2010US20100150909 PTHrP-DERIVED MODULATORS OF SMOOTH MUSCLE PROLIFERATION
06/17/2010US20100150904 Binding members for ige molecules
06/17/2010US20100150902 Anti-cd151 antibodies and their use in the treatment of cancer
06/17/2010US20100150901 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
06/17/2010US20100150877 Osteopontin for the Prediction and Treatment of Cardiovascular Diseases
06/17/2010US20100150860 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen, and pharmaceutical composition thereof
06/17/2010CA2748691A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/17/2010CA2747244A1 Cell-based detection of apf through its interaction with ckap4 for diagnosis of interstitial cystitis
06/17/2010CA2744004A1 Compositions and methods for detecting small rnas, and uses thereof
06/16/2010EP2196544A1 Kit for ligation detection assays using codeable labels
06/16/2010EP2195453A2 Method of amplifying nucleic acid
06/16/2010EP2195426A2 System for capturing and modifying large pieces of genomic dna and constructing organisms with synthetic chloroplasts
06/16/2010EP2195338A1 N-terminal modified interferon-alpha
06/16/2010EP2195035A1 High concentration chitosan-nucleic acid polyplex compositions
06/16/2010EP1622921B1 Variants of beta-glucosidases
06/16/2010EP1587816B1 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
06/16/2010EP1579004B1 Screening methods for identification of efficient pre-trans-splicing molecules
06/16/2010CN1984921B Modulation of survivin expression
06/16/2010CN1904034B Novel bacterium and vaccine
06/16/2010CN1894276B HCV NS3-NS4A protease resistance mutants
06/16/2010CN1875029B Expression in filamentous fungi of protease inhibitors and variants thereof
06/16/2010CN1653079B Intercalator containing pseudonucleotide(s)
06/16/2010CN101743251A Peptides with anitfungal activity
06/16/2010CN101735297A Method for quickly extracting low molecular weight RNA of plant
06/15/2010US7737330 a polynucleotide comprising a nucleotide sequence or complement encoding a polypeptide comprising a farnesyltranstransferase beta subunit, used to improve tolerance to drought in mature plants
06/15/2010US7737329 Polynucleotides encoding proteins involved in plant metabolism
06/15/2010US7737326 DNA construct containing genetic enhancers linked to genes or antisense DNA, edxpressed in plants and seeds, for imparting agronomically useful traits such as increase in yield, disease resistance, insect resistance, herbicide tolerance, drought tolerance and salt tolerance in plants
06/15/2010US7737268 Separating double and single stranded DNA sequences via exposure to silica particles, chaotropic agents, chelating compounds and hydrogen ion concentration change; DNA extraction
06/15/2010US7737267 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
06/15/2010US7737266 double-stranded ribonucleic acid for inhibiting the expression of sterol regulatory element binding proteins (SREPB) cleavage activating protein (SCAP) genes in cells
06/15/2010US7737265 RNAi modulation of HIF-1 and therapeutic uses thereof
06/15/2010US7737264 Oligomeric compounds for the modulation HIF-1α expression
06/15/2010US7737262 For primates; p42 nucleic acid encoding a p42 polypeptide from the C-terminal processing fragment of Plasmodium falciparum major merozoite surface protein gp195 which hybridizes under high stringency conditions
06/15/2010US7737257 Connective tissue growth factor (CTGF-3)
06/15/2010US7737125 oligonucleotide compounds (oligomers), which target androgen receptor mRNA in a cell, leading to reduced expression of the androgen receptor; reduction of androgen receptor expression is beneficial for treatment of certain disorders, such as hyperproliferative disorders (e.g., cancer)
06/15/2010US7737124 transfecting a packaging cell line with a retroviral construct, then recovering a recombinant retrovirus from the packaging cell line and infecting a target cell ex vivo with the recombinant retrovirus; downregulating chemokine receptors (CCR5); treatment of viral diseases
06/15/2010US7737110 increasing ratio of wild type IKBKAP mRNA to misspliced IKBKAP mRNA in cells where misspliced IKBKAP mRNA is transcribed from mutant IKBKAP gene expressing wild type and misspliced IKBKAP mRNA by contacting cells possessing mutant IKBKAP gene with kinetin to increase ratio of wild type to misspliced mRNA
06/15/2010US7737089 Photoactivatable two-stage protective groups for the synthesis of biopolymers
06/15/2010US7737088 Method and device for producing biochemical reaction supporting materials
06/15/2010US7736906 Preparing olionucleotide and/or peptide sequences on single substrate
06/15/2010US7736898 a eukaryotic expression vector comprising a recombinant nucleotide sequence encoding hydrolase enzymes, used to induce apoptosis in vertebrate cells in vivo by reducing the level of thiamine in the cells; inducing apoptosis in cancer cells
06/15/2010US7736882 biosynthesis of isopentenyl pyrophosphate, terpenes and steroids, using cultures of transformed microorganisms comprising nucleotide sequences that code mevalonate pathway enzymes
06/15/2010US7736878 Recombinant forms of DNA sequences for a cyclobutane pyrimidine dimer (CPD) glycosylase protein, that are capable of expression at high level, used in topical formulations for treatment of photosensitive or autoimmune disease that are exacerbated by DNA damage from UV light exposure, such as lupus
06/15/2010US7736876 Peptide-forming enzyme gene
06/15/2010US7736871 Nucleotide sequences coding dipeptide forming enzyme
06/15/2010US7736870 Nucleic acid sequences having gene transcription regulatory qualities
06/15/2010US7736869 nucleotide or DNA constructs comprising expression cassettes comprising promoters operably linked to transgene open reading frames, used in protein production, diagnostics, transgenic plants and animals and the therapeutic field
06/15/2010US7736868 Nucleic acid sequences having gene transcription regulatory qualities
06/15/2010US7736862 screening for high affinity agonists, antagonists and inverse agonists of taste activity; Such compounds could be useful as additives in foods, beverages and drugs
06/15/2010US7736858 Using non-invasive bioassay/immunoassay for differentiating between clinical subtypes of inflammatory bowel disease
06/15/2010US7736854 Methods of detection of a target nucleic acid sequence
06/15/2010US7736852 determining the predisposition or susceptibility to bipolar disorder, by detecting the presence of polymorphism in a vesicular monoamine transporter 1 (VMAT1) gene or haplotype; treatment of psychological disorders, using a composition that encodes a VMAT protein or modulates it's gene expression
06/15/2010US7736851 Using recombinase mediated homologous recombination to stably intergrate preferential nucleotide sequences into cells; gene therapy and tissue engineering
06/15/2010US7736680 Using mutations to improve Aspergillus phytases
06/15/2010US7736657 Fusion constructs containing active sections on TNF ligands
06/15/2010US7736654 Proteins, polynucleotides, antibodies, transgenic animals, hybridoma; humoral or cellular immune response; pancreatic
06/15/2010US7736650 recombinant expression vectors and plasmids comprising restriction sites for cloning antibodies
06/15/2010US7736645 inhibiting angiogenesis in tissues expressing a endocrine gland-derived vascular endothelial growth factor(EG-VEGF) polypeptide, comprising contacting the tissue with an antagonist antibody of the EG-VEGF polypeptide or an antigen binding fragment; regulating cellular proliferation and chemotaxis
06/15/2010US7736643 A mutant hydrolase protein of Candida comprising an amino acid sequence, where the #219 leucine is replaced by a hydrophilic amino acid selected from glutamine, histidine, arginine, lysine, serine, threonine, aspartic acid and glutamic acid, used in the food and detergent industry
06/15/2010CA2320288C Oligodeoxyribonucleotides comprising o6-benzylguanine and their use
06/10/2010WO2010065953A1 T cell receptor alpha genes which predispose the airway to bacterial colonization
06/10/2010WO2010065834A1 Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
06/10/2010WO2010065079A2 Antibodies to il-6 and use thereof
06/10/2010WO2010065077A2 Antagonists of il-6 to prevent or treat thrombosis
06/10/2010WO2010064146A2 Method for the synthesis of phosphorus atom modified nucleic acids
06/10/2010WO2010045384A3 Short hairpin rnas for inhibition of gene expression
06/10/2010WO2010039615A3 Papio cynocephalus toll-like receptor 3
06/10/2010WO2010027512A3 Rna synthesis - phosphoramidites for synthetic rna in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic rna at the 3' - end